Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial)
- Citation:
- Breast Cancer Res Treat vol 132 (3) 871-879
- Year:
- 2012
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 699
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Cheryl Lin Meredith Becker Buxton Dan Moore Helen Krontiras Lisa Carey Angela DeMichele Leslie Montgomery Debasish Tripathy Constance Lehman Minetta Liu Olufunmilayo Olapade Christina Yau Donald Berry Laura J. Esserman
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-150007, CALGB-150012
- Phases:
- N/A
- Keywords:
- Screening, Neoadjuvant, Interval cancer